Hypothesis\n\nSleep‑dependent glymphatic clearance actively sets the chromatin state of the CDKN2A/B locus by modulating EZH2‑mediated H3K27me3 deposition; loss of this nightly editing permits p16INK4a‑driven senescence, which in turn impairs glymphatic flow, creating a self‑reinforcing loop that accelerates brain aging.\n\n## Mechanistic Rationale\n\nDuring NREM sleep, the glymphatic influx of cerebrospinal fluid clears interstitial metabolites such as lactate and NADH. High concentrations of these redox‑active molecules inhibit EZH2 enzymatic activity in vitro, reducing H3K27me3 at target promoters. When glymphatic flow is robust, metabolite levels stay low, EZH2 remains active, and the CDKN2A/B promoter retains repressive H3K27me3 marks, keeping p16INK4a transcription silent. Chronic sleep disruption diminishes glymphatic clearance, allowing metabolites to accumulate, EZH2 activity drops, H3K27me3 erodes, and CDKN2A/B becomes derepressed. The resulting rise in p16INK4a pushes astrocytes and microglia into a senescent state. Senescent glial cells secrete SASP factors (e.g., TGF‑β, MMP‑9) that alter extracellular matrix composition and aquaporin‑4 polarization, further hindering glymphatic inflow. Thus, a feed‑forward cycle links impaired waste clearance to epigenetic aging and vice‑versa.\n\n## Testable Predictions\n\n1. Mice subjected to chronic sleep fragmentation will show reduced CSF influx (measured by MRI‑based glymphatic imaging) concurrent with decreased H3K27me3 and increased p16INK4a expression in cortical astrocytes.\n2. Pharmacological enhancement of glymphatic flow (e.g., via low‑dose acetazolamide) during sleep deprivation will rescue EZH2 activity, preserve H3K27me3 at the CDKN2A/B promoter, and prevent p16INK4a up‑regulation.\n3. Conditional deletion of EZH2 in astrocytes will mimic the effects of sleep loss on CDKN2A/B expression and exacerbate glymphatic dysfunction, even when sleep is intact.\n4. Senolytic clearance of p16INK4a‑positive glia in sleep‑fragmented animals will restore aquaporin‑4 perivascular localization and improve CSF clearance, breaking the feedback loop.\n\n## Experimental Approach\n\n- Use awake‑imaging glymphatic tracking in mice with EEG‑defined NREM sleep to correlate sleep quality with real‑time CSF tracer kinetics.\n- Perform ChIP‑qPCR for H3K27me3 and RNA‑FISH for p16INK4a in FACS‑sorted astrocytes after sleep manipulation.\n- Apply EZH2 inhibitor (GSK126) or activator (e.g., S-adenosylmethionine supplementation) to test causality.\n- Quantify SASP biomarkers in interstitial fluid and assess aquaporin‑4 polarity via immunohistochemistry.\n- Evaluate functional outcomes with Morris water maze and electrophysiological LTP to link molecular changes to cognition.\n\nThis framework turns the metaphor of a nightly 'autopsy' into a concrete epigenetic checkpoint: sleep decides which neural architectures survive by governing the glymphatic‑EZH2‑CDKN2A/B axis, and senescence rewrites the very clearance mechanism that protects them.